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Progressive supranuclear palsy (PSP) is a neurodegenerative condition marked by supranuclear 
ophthalmoplegia, pseudobulbar palsy, and gait instability leading to repeated falls. We undertook a 
systematic review to determine how the rate of falls was measured in PSP studies; a cardinal feature 
of the condition.  We searched Pubmed using following the search terms,: (("progressive 
supranuclear palsy" OR PSP OR "Steele-Richardson-Olszewski syndrome") AND falls), as well as an 
performing an individual search of the MeSH terms “progressive supranuclear palsy AND accidental 
falls”, up to March 2019. Papers were included if they reported the incidence of falling and were in 
English. All study designs were included (observational or interventional) as long as they included 
more than one participant.   
Thirty papers were identified with a mean number of participants of 47.6 (range 8-350). Study 
designs ranged from prospective and retrospective cohorts to small scale trials.  
Only two studies documented an absolute number of falls using a falls diary (the established gold 
standard)[1], or mean number of falls per patient. A study by Zwergal et al. reported a total of 195 
falls occurring in 16 patients (mean 11.8 (range 1-40) over a six month period [2]. Another study 
reported by Clerici et al. demonstrated a mean of 7 and 8 falls over a one month period from 12 
patients at baseline prior to allocation to two rehabilitation programmes [3]. A Further paper 
(Srulijes et al.) reported a quantitative falls rate of 46.2 per year for a whole cohort in a comparative 
study of PSP patients (n=12) compared to other neurodegenerative diseases. [4] A selection of other 
studies quantified falls prospectively but did not report quantitative data for falls values at 
publication. The majority of studies used either medical record review or a semi-quantitative ordinal 
scale as found in the PSPRS (Progressive Supranuclear Palsy Rating Scale) or UPDRS (Unified 
Parkinson’s Disease Rating Scale) [5,6]. Patients were usually divided into arbitrary groups such as 
“frequent” or “infrequent” fallers, with inconsistent cut-offs. Where medical records were reviewed, 
a binary variable (presence or absence of falls) was usually recorded.  
It is surprising that few studies have sought to provide prospective data on fall frequency given that 
falls are a major feature in PSP.  The PSPRS captures falls as an ordinal variable (0=None in the past 
year, 1= <1 per month, 2=1-4 per month, 3=5-30 per month, 4 > 30 per month or chairbound). This 
can be used for comparing group differences but does not provide an absolute difference in falls rate 
and has an unbounded top category. Additionally, the score is retrospective relying on patient/carer 
recall with a greater degree of measurement error and potential recall bias. However, where 
retrospective studies are performed and falls data collected, we appreciate that collecting absolute 
data retrospectively may also be obscured by recall bias making a truly accurate picture hard to 
obtain. We advocate that future PSP studies should collect falls data using the current gold standard 
ProFANE (Prevention of Falls Network Europe) methods [1], and that a prospective approach is best. 
This will provide more useful and reliable data on falls in this high risk population and enable better 
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